1. Home
  2. GUTS vs ELUT Comparison

GUTS vs ELUT Comparison

Compare GUTS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUTS
  • ELUT
  • Stock Information
  • Founded
  • GUTS 2010
  • ELUT 2015
  • Country
  • GUTS United States
  • ELUT United States
  • Employees
  • GUTS N/A
  • ELUT N/A
  • Industry
  • GUTS
  • ELUT Medical Specialities
  • Sector
  • GUTS
  • ELUT Health Care
  • Exchange
  • GUTS NYSE
  • ELUT Nasdaq
  • Market Cap
  • GUTS 110.1M
  • ELUT 128.3M
  • IPO Year
  • GUTS 2024
  • ELUT 2020
  • Fundamental
  • Price
  • GUTS $1.42
  • ELUT $3.22
  • Analyst Decision
  • GUTS Buy
  • ELUT Strong Buy
  • Analyst Count
  • GUTS 2
  • ELUT 2
  • Target Price
  • GUTS $10.00
  • ELUT $10.00
  • AVG Volume (30 Days)
  • GUTS 336.9K
  • ELUT 37.7K
  • Earning Date
  • GUTS 03-04-2025
  • ELUT 03-06-2025
  • Dividend Yield
  • GUTS N/A
  • ELUT N/A
  • EPS Growth
  • GUTS N/A
  • ELUT N/A
  • EPS
  • GUTS N/A
  • ELUT N/A
  • Revenue
  • GUTS $97,000.00
  • ELUT $24,782,000.00
  • Revenue This Year
  • GUTS N/A
  • ELUT $3.88
  • Revenue Next Year
  • GUTS N/A
  • ELUT $34.52
  • P/E Ratio
  • GUTS N/A
  • ELUT N/A
  • Revenue Growth
  • GUTS N/A
  • ELUT N/A
  • 52 Week Low
  • GUTS $1.37
  • ELUT $2.28
  • 52 Week High
  • GUTS $10.50
  • ELUT $5.24
  • Technical
  • Relative Strength Index (RSI)
  • GUTS 35.96
  • ELUT 55.09
  • Support Level
  • GUTS $1.37
  • ELUT $2.83
  • Resistance Level
  • GUTS $1.70
  • ELUT $3.00
  • Average True Range (ATR)
  • GUTS 0.13
  • ELUT 0.26
  • MACD
  • GUTS -0.01
  • ELUT 0.09
  • Stochastic Oscillator
  • GUTS 11.11
  • ELUT 91.01

About GUTS FRACTYL HEALTH INC

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: